BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30940634)

  • 1. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.
    Sahin I; Kawano Y; Sklavenitis-Pistofidis R; Moschetta M; Mishima Y; Manier S; Sacco A; Carrasco R; Fonseca R; Roccaro AM; Witzig T; Ghobrial IM
    Blood Adv; 2019 Apr; 3(7):995-1002. PubMed ID: 30940634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citron kinase (CIT-K) promotes aggressiveness and tumorigenesis of breast cancer cells in vitro and in vivo: preliminary study of the underlying mechanism.
    Meng D; Yu Q; Feng L; Luo M; Shao S; Huang S; Wang G; Jing X; Tong Z; Zhao X; Liu R
    Clin Transl Oncol; 2019 Jul; 21(7):910-923. PubMed ID: 30565087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating cytokinesis failure as a strategy in cancer therapy.
    McKenzie C; D'Avino PP
    Oncotarget; 2016 Dec; 7(52):87323-87341. PubMed ID: 27895316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citron kinase controls abscission through RhoA and anillin.
    Gai M; Camera P; Dema A; Bianchi F; Berto G; Scarpa E; Germena G; Di Cunto F
    Mol Biol Cell; 2011 Oct; 22(20):3768-78. PubMed ID: 21849473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sahin I, Kawano Y, Sklavenitis-Pistofidis R, et al. Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma. Blood Adv. 2019;3(7):995-1002.
    Blood Adv; 2024 Apr; 8(8):1958. PubMed ID: 38619855
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue-specific control of midbody microtubule stability by Citron kinase through modulation of TUBB3 phosphorylation.
    Sgrò F; Bianchi FT; Falcone M; Pallavicini G; Gai M; Chiotto AM; Berto GE; Turco E; Chang YJ; Huttner WB; Di Cunto F
    Cell Death Differ; 2016 May; 23(5):801-13. PubMed ID: 26586574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-regulation between Aurora B and Citron kinase controls midbody architecture in cytokinesis.
    McKenzie C; Bassi ZI; Debski J; Gottardo M; Callaini G; Dadlez M; D'Avino PP
    Open Biol; 2016 Mar; 6(3):. PubMed ID: 27009191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
    Liu Z; Yan H; Yang Y; Wei L; Xia S; Xiu Y
    Biomed Pharmacother; 2020 Apr; 124():109830. PubMed ID: 31972359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citron kinase controls a molecular network required for midbody formation in cytokinesis.
    Bassi ZI; Audusseau M; Riparbelli MG; Callaini G; D'Avino PP
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9782-7. PubMed ID: 23716662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citron kinase - renaissance of a neglected mitotic kinase.
    D'Avino PP
    J Cell Sci; 2017 May; 130(10):1701-1708. PubMed ID: 28468989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Citron Rho-interacting serine/threonine kinase knockdown suppresses prostate cancer cell proliferation and metastasis by blocking Hippo-YAP pathway].
    Haiping C; Qi X; Dawei L; Qiang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):257-263. PubMed ID: 31068310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-pore channel 1 interacts with citron kinase, regulating completion of cytokinesis.
    Horton JS; Wakano CT; Speck M; Stokes AJ
    Channels (Austin); 2015; 9(1):21-9. PubMed ID: 25665131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference targeting CITRON can significantly inhibit the proliferation of hepatocellular carcinoma cells.
    Fu Y; Huang J; Wang KS; Zhang X; Han ZG
    Mol Biol Rep; 2011 Feb; 38(2):693-702. PubMed ID: 20369383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of KIF14 cause primary microcephaly by impairing cytokinesis.
    Moawia A; Shaheen R; Rasool S; Waseem SS; Ewida N; Budde B; Kawalia A; Motameny S; Khan K; Fatima A; Jameel M; Ullah F; Akram T; Ali Z; Abdullah U; Irshad S; Höhne W; Noegel AA; Al-Owain M; Hörtnagel K; Stöbe P; Baig SM; Nürnberg P; Alkuraya FS; Hahn A; Hussain MS
    Ann Neurol; 2017 Oct; 82(4):562-577. PubMed ID: 28892560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma.
    Cong L; Bai Z; Du Y; Cheng Y
    Biomed Res Int; 2020; 2020():9210891. PubMed ID: 32185224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27(Kip1) controls cytokinesis via the regulation of citron kinase activation.
    Serres MP; Kossatz U; Chi Y; Roberts JM; Malek NP; Besson A
    J Clin Invest; 2012 Mar; 122(3):844-58. PubMed ID: 22293177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sticky/Citron kinase maintains proper RhoA localization at the cleavage site during cytokinesis.
    Bassi ZI; Verbrugghe KJ; Capalbo L; Gregory S; Montembault E; Glover DM; D'Avino PP
    J Cell Biol; 2011 Nov; 195(4):595-603. PubMed ID: 22084308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citron kinase mediates transition from constriction to abscission through its coiled-coil domain.
    Watanabe S; De Zan T; Ishizaki T; Narumiya S
    J Cell Sci; 2013 Apr; 126(Pt 8):1773-84. PubMed ID: 23444367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in CIT, encoding citron rho-interacting serine/threonine kinase, cause severe primary microcephaly in humans.
    Shaheen R; Hashem A; Abdel-Salam GM; Al-Fadhli F; Ewida N; Alkuraya FS
    Hum Genet; 2016 Oct; 135(10):1191-7. PubMed ID: 27503289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIF14 and citron kinase act together to promote efficient cytokinesis.
    Gruneberg U; Neef R; Li X; Chan EH; Chalamalasetty RB; Nigg EA; Barr FA
    J Cell Biol; 2006 Jan; 172(3):363-72. PubMed ID: 16431929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.